Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
13 Jul 2024 |
RP04AP01 |
Second filing for the appointment of Mr Jerome Marie Joseph Charton as a director
|
|
|
16 May 2024 |
AP03 |
Appointment of Mr Richard Edward Adair as a secretary on 30 April 2024
|
|
|
16 May 2024 |
AP01 |
Appointment of Mr Jerome Marie Joseph Charton as a director on 30 April 2024
-
ANNOTATION
Clarification a second filed AP01 was registered on 13/07/24
|
|
|
08 Apr 2024 |
AA |
Audit exemption subsidiary accounts made up to 30 June 2023
|
|
|
08 Apr 2024 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 30/06/23
|
|
|
08 Apr 2024 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 30/06/23
|
|
|
08 Apr 2024 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 30/06/23
|
|
|
16 Feb 2024 |
CS01 |
Confirmation statement made on 16 February 2024 with no updates
|
|
|
26 Jan 2024 |
TM01 |
Termination of appointment of David John Bryant as a director on 26 January 2024
|
|
|
03 May 2023 |
AA |
Audit exemption subsidiary accounts made up to 30 June 2022
|
|
|
03 May 2023 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 30/06/22
|
|
|
03 May 2023 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 30/06/22
|
|
|
03 May 2023 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 30/06/22
|
|
|
21 Feb 2023 |
CS01 |
Confirmation statement made on 17 February 2023 with updates
|
|
|
31 Jan 2023 |
TM02 |
Termination of appointment of Amanda Miller as a secretary on 16 January 2023
|
|
|
01 Apr 2022 |
AA |
Audit exemption subsidiary accounts made up to 30 June 2021
|
|
|
01 Apr 2022 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 30/06/21
|
|
|
01 Apr 2022 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 30/06/21
|
|
|
01 Apr 2022 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 30/06/21
|
|
|
17 Feb 2022 |
CS01 |
Confirmation statement made on 17 February 2022 with updates
|
|
|
03 Dec 2021 |
PSC07 |
Cessation of Quantum Pharmaceutical Limited as a person with significant control on 25 June 2021
|
|
|
03 Dec 2021 |
PSC02 |
Notification of Clinigen Pharma Limited as a person with significant control on 25 June 2021
|
|
|
12 Aug 2021 |
AD01 |
Registered office address changed from 25 Bedford Square Bloomsbury London WC1B 3HW United Kingdom to 25 Bedford Square Bloomsbury London WC1B 3HH on 12 August 2021
|
|
|
02 Jul 2021 |
TM01 |
Termination of appointment of David Alan Sanson as a director on 30 June 2021
|
|
|
24 Jun 2021 |
AD01 |
Registered office address changed from Quantum House Hobson Industrial Estate Burnopfield County Durham NE16 6EA United Kingdom to 25 Bedford Square Bloomsbury London WC1B 3HW on 24 June 2021
|
|